The company said net sales for Q4 2025 were $1,693 million, roughly flat from $1,689 million a year earlier, and organic sales fell 1%. GAAP loss from continuing operations was $(108) million, and operating EBITDA was $409 million.

1. 01

   The company said net sales for Q4 2025 were $1,693 million, roughly flat from $1,689 million a year earlier, and organic sales fell 1%. GAAP loss from continuing operations was $(108) million, and operating EBITDA was $409 million.

2. 02

   DuPont said full-year 2025 net sales rose 2% to $6,849 million. GAAP income from continuing operations was $98 million, operating EBITDA was $1,628 million, and adjusted EPS was $1.68. Adjusted EPS was $1.45 a year earlier.

3. 03

   The company said cash provided by operating activities from continuing operations for 2025 was $560 million. After capital expenditures of $333 million and separation-related transaction cost and other payments of $462 million, transaction-adjusted free cash flow was $689 million.

4. 04

   DuPont gave full-year 2026 net sales guidance of $7,075 million to $7,135 million and adjusted EPS guidance of $2.25 to $2.30. It said the pre-tax cash proceeds from the Aramids divestiture are about $1.2 billion and that the deal is expected to close around the end of Q1 2026.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.